Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, Fusarenon X, and nivalenol

Toxicological Sciences

Volumn 138, Issue 2, 2014, Pages 278-289

  Wu, Wenda ^a,b   Zhou, Hui Ren ^b   He, Kaiyu ^c,d   Pan, Xiao ^c   Sugita Konishi, Yoshiko ^e   Watanabe, Maiko ^e   Zhang, Haibin ^a   Pestka, James J ^b,c,d,f  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Department of Microbiology and Molecular Genetics Michigan State University ^*  (United States)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^f AZABU UNIVERSITY   (Japan)

Author keywords

15 acetyldeoxynivalenol; 3 acetyldeoxynivalenol; Anorexia; Deoxynivalenol; Fusarenon X; Mycotoxin; Nivalenol; Trichothecene

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 15 ACETYLVOMITOXIN; 3 ACETYLDEOXYNIVALENOL; 8 KETOTRICHOTHECENE DERIVATIVE; CHOLECYSTOKININ; FUSARENON X; LINTITRIPT; NIVALENOL; PEPTIDE YY [3-36]; TRICHOTHECENE DERIVATIVE; UNCLASSIFIED DRUG; VOMITOXIN;

ANOREXIA; ARTICLE; CHEMICAL STRUCTURE; FOOD INTAKE; FUSARIUM GRAMINEARUM; PROTEIN SECRETION;

15-ACETYLDEOXYNIVALENOL; 3-ACETYLDEOXYNIVALENOL; ANOREXIA; DEOXYNIVALENOL; FUSARENON X; MYCOTOXIN; NIVALENOL; TRICHOTHECENE;

ADMINISTRATION, ORAL; ANIMALS; ANOREXIA; CHOLECYSTOKININ; FEMALE; MICE; MYCOTOXINS; PEPTIDE FRAGMENTS; PEPTIDE YY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; TRICHOTHECENES;

EID: 84896487537     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft335     Document Type: Article

References (54)

1. Acosta, A., Hurtado, M. D., Gorbatyuk, O., La Sala, M., Duncan, D., Aslanidi, G., Campbell-Thompson, M., Zhang, L., Herzog, H., Voutetakis, A., et al. (2011). Salivary PYY: A putative bypass to satiety. PloS one 6, e26137.
2. Azcona-Olivera, J. I.,Ouyang, Y., Murtha, J., Chu, F. S., and Pestka, J. J. (1995). Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Relationship to toxin distribution and protein synthesis inhibition. Toxicol. Appl. Pharmacol. 133, 109-120.
3. Baptista, V., Browning, K. N., and Travagli, R. A. (2007). Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R1092-R1100.
4. Batterham, R., Le Roux, C., Cohen, M., Park, A., Ellis, S., Patterson, M., Frost, G., Ghatei, M., and Bloom, S. (2003a). Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrin. Metab. 88, 3989-3992.
5. Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., and Bloom, S. R. (2003b). Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349, 941-948.
6. Batterham, R. L., Cowley,M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L.,Wren, A. M., Brynes, A. E., Low,M. J., and Ghatei, M. A. (2002). Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418, 650-654.
7. Beinfeld, M., Meyer, D., and Brownstein, M. (1981). Cholecystokinin in the central nervous system. Peptides 2, 77-79.
8. Blandizzi, C., Lazzeri, G., Colucci, R., Carignani, D., Tognetti, M., Baschiera, F., and Del Tacca, M. (1999). CCK1 and CCK2 receptors regulate gastric pepsinogen secretion. Eur. J. Pharmacol. 373, 71-84.
9. Brown, T. A., Washington, M. C., Metcalf, S. A., and Sayegh, A. I. (2011). The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves. Peptides 32, 1581-1586.
10. Cano, V., Ezquerra, L., Ramos, M. P., and Ruiz-Gayo, M. (2003). Regulation of leptin distribution between plasma and cerebrospinal fluid by cholecystokinin receptors. Brit. J. Pharmacol. 140, 647-652.
11. Challis, B., Pinnock, S., Coll, A., Carter, R., Dickson, S., and O'rahilly, S. (2003). Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem. Biophys. Res. Com. 311, 915-919.
12. Chen, H., Kent, S., and Morris, M. J. (2006). Is the CCK2 receptor essential for normal regulation of body weight and adiposity? Eur. J. Neurosci. 24, 1427-1433.
13. Clerc, P., Coll Constans, M. G., Lulka, H., Broussaud, S., Guigne, C., Leung-Theung-Long, S., Perrin, C., Knauf, C., Carpene, C., Penicaud, L., et al. (2007). Involvement of cholecystokinin 2 receptor in food intake regulation: Hyperphagia and increased fat deposition in cholecystokinin 2 receptordeficient mice. Endocrinology 148, 1039-1049.
14. Corp, E. S., Curcio, M., Gibbs, J., and Smith, G. P. (1997). The effect of centrally administered CCK-receptor antagonists on food intake in rats. Physiol. Behav. 61, 823-827.
15. Crawley, J. N., and Corwin, R. L. (1994). Biological actions of cholecystokinin. Peptides 15, 731-755.
16. Della-Fera, M. A., and Baile, C. A. (1980). CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep. Peptides 1, 51-54.
17. Dockray, G. J. (2009). Cholecystokinin and gut-brain signalling. Regul. Pept. 155, 6-10.
18. Dorre, D., and Smith, G. P. (1998). Cholecystokinin(B) receptor antagonist increases food intake in rats. Physiol. Behav. 65, 11-14.
19. Dourish, C. T., Rycroft,W., and Iversen, S. D. (1989). Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245, 1509-1511.
20. Dufresne, M., Seva, C., and Fourmy, D. (2006). Cholecystokinin and gastrin receptors. Physiol. Rev. 86, 805-847.
21. Ebenezer, I., De La Riva, C., and Baldwin, B. (1990). Effects of the CCK receptor antagonist MK-329 on food intake in pigs. Physiol. Behav. 47, 145-148.
22. Flannery, B. M., Amuzie, C. J., and Pestka, J. J. (2013). Evaluation of insulinlike growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression. Toxicology 304, 192-198.
23. Flannery, B. M., Clark, E. S., and Pestka, J. J. (2012). Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide yy. Toxicol. Sci. 130, 289-297.
24. Flannery, B. M., Wu, W., and Pestka, J. J. (2011). Characterization of deoxynivalenol-induced anorexia using mouse bioassay. Food Chem. Toxicol. 49, 1863-1869.
25. Forsell, J. H., Witt, M. F., Tai, J. H., Jensen, R., and Pestka, J. J. (1986). Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem. Toxicol. 24, 213-219.
26. Frommelt, L., Lembke, V., Hofmann, T., Goebel-Stengel, M., Monnikes, H., Wiedenmann, B., Klapp, B. F., Stengel, A., and Kobelt, P. (2013). The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway. Peptides 39, 111-118.
27. Girardet, C., Bonnet, M. S., Jdir, R., Sadoud, M., Thirion, S., Tardivel, C., Roux, J., Lebrun, B., Wanaverbecq, N., and Mounien, L. (2011). The foodcontaminant deoxynivalenol modifies eating by targeting anorexigenic neurocircuitry. PloS one 6, e26134.
28. Guilloteau, P., Le Meuth-Metzinger, V., Morisset, J., and Zabielski, R. (2006). Gastrin, cholecystokinin and gastrointestinal tract functions in mammals. Nutr. Res. Rev. 19, 254-283.
29. Hao, S., Sternini, C., and Raybould, H. E. (2008). Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R33-R38.
30. Holmes, G. M., Tong, M., and Travagli, R. A. (2009). Effects of brain stem cholecystokinin-8s on gastric tone and esophageal-gastric reflex. Am. J. Physiol. Gastro. Liver Physiol. 296, G621-G631.
31. Hörsten, S., Hoffmann, T., Alfalah, M., Wrann, C., Karl, T., Pabst, R., and Bedoui, S. (2004). PP, PYY and NPY: Synthesis, storage, release and degradation. Neuropept. Y Relat. Pept. 162, 23-44.
32. Hurtado, M. D., Sergeyev, V. G., Acosta, A., Spegele, M., La Sala, M., Waler, N. J., Chiriboga-Hurtado, J., Currlin, S. W., Herzog, H., Dotson, C. D., et al.(2013). Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion. J. Neurosci. 33, 18368-18380.
33. Iverson, F., Armstrong, C., Nera, E., Truelove, J., Fernie, S., Scott, P., Stapley, R., Hayward, S., and Gunner, S. (1995). Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog. Carcinog. Mutagen. 15, 283-306.
34. JECFA (2011). Evaluation of Certain Contaminants in Food: 72nd Report of the Joint FAO/WHO Expert Committee on Food Additives. In Deoxynivalenol, WHO Technical Report Series No. 959, pp. 37-48. WHO Press, Geneva, Switzerland.
35. Kohno, D., Nakata, M., Maejima, Y., Shimizu, H., Sedbazar, U., Yoshida, N., Dezaki, K., Onaka, T., Mori, M., and Yada, T. (2008). Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149, 1295-1301.
36. Kopin, A. S., Mathes, W. F., McBride, E. W., Nguyen, M., Al-Haider, W., Schmitz, F., Bonner-Weir, S., Kanarek, R., and Beinborn, M. (1999). The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J. Clin. Invest. 103, 383-391.
37. Lotti, V. J., Chang, R. S., Kling, P. J., and Cerino, D. J. (1986). Evidence that cholecystokinin octapeptide (CCK-8) acts as a potent, full agonist on gastrin receptors for acid secretion in the isolated mouse stomach: Lack of antagonism by the specific CCK antagonist asperlicin. Digestion 35, 170-174.
38. Miyasaka, K., Ichikawa,M., Ohta, M., Kanai, S., Yoshida, Y., Masuda,M., Nagata, A., Matsui, S., Noda, T., Takiguchi, S., et al. (2002). Energymetabolism and turnover are increased in mice lacking the cholecystokinin-B receptor. J. Nutri. 132, 739-741.
39. Nibha, K. P., and Pancholi, S. S. (2012). An overview on: Sublingual route for systemic drug delivery. Int. J. Res. Pharmaceut. Biomed. Sci. 3, 913-923.
40. Pestka, J. J. (2010a). Deoxynivalenol: Mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 84, 663-679.
41. Pestka, J. J. (2010b). Toxicological mechanisms and potential health effects of deoxynivalenol and nivalenol. World Mycotoxin J. 3, 323-347.
42. Pestka, J. J., Islam, Z., and Amuzie, C. J. (2008). Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse. Toxicol. Letts. 178, 83-87.
43. Poapolathep, A., Sugita-Konishi, Y., Doi, K., and Kumagai, S. (2003). The fates of trichothecenemycotoxins, nivalenol and fusarenon-X, in mice. Toxicon 41, 1047-1054.
44. Polak, J. M., Bloom, S., Rayford, P., Pearse, A., Buchan, A., and Thompson, J. (1975). Identification of cholecystokinin-secreting cells. The Lancet 306, 1016-1018.
45. Poncelet, M., Arnone, M., Heaulme, M., Gonalons, N., Gueudet, C., Santucci, V., Thurneyssen, O., Keane, P., Gully, D., Le Fur, G., et al. (1993). Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn Schmiedebergs Arch. Pharmacol. 348, 102-107.
46. Rehfeld, J. F., Hansen, H. F., Marley, P. D., and Stengaardpedersen, K. (1985). Molecular-forms of cholecystokinin in the brain and the relationship to neuronal gastrins. Ann. N.Y. Acad. Sci. 448, 11-23.
47. Reidelberger, R. D., Hernandez, J., Fritzsch, B., and Hulce, M. (2004). Abdominal vagal mediation of the satiety effects of CCK in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R1005-R1012.
48. Rogers, R. C., and Hermann, G. E. (2008). Mechanisms of action of CCK to activate central vagal afferent terminals. Peptides 29, 1716-1725.
49. Schwartz, M. W. (2006). Central nervous system regulation of food intake. Obesity 14, 1S-8S.
50. Steinert, R. E., Feinle-Bisset, C., Geary, N., and Beglinger, C. (2013). Secretion of gastrointestinal hormones and eating control. J. Anim. Sci. 91, 1963-1973.
51. Strader, A. D., and Woods, S. C. (2005). Gastrointestinal hormones and food intake. Gastroenterology 128, 175-191.
52. Weiland, T. J., Voudouris, N. J., and Kent, S. (2004). The role of CCK2 receptors in energy homeostasis: Insights from the CCK2 receptor-deficient mouse. Physiol. Behav. 82, 471-476.
53. Wu, W., Flannery, B. M., Sugita-Konishi, Y., Watanabe, M., Zhang, H., and Pestka, J. J. (2012). Comparison of murine anorectic responses to the 8-ketotrichothecenes 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, fusarenon X and nivalenol. Food Chem. Toxicol. 50, 2056-2061.
54. Zhang, D.-M., Bula, W., and Stellar, E. (1986). Brain cholecystokinin as a satiety peptide. Physiol. Behav. 36, 1183-1186.